نتایج جستجو برای: ãÿ

تعداد نتایج: 127  

2006
Susan A. Rotenberg Stephen Smiley Marius Ueffing Robert S. Krauss Lan Bo Chen Bernard Weinstein

Dequalinium has previously been shown to be an anticarcinoma agent (M. J. Weiss et al., Proc. Nati. Acad. Sci. USA, 84: 5444-5448, 1987). The present study demonstrates that it can inhibit protein kinase C-ß, isolated from an overproducing cell line with a 50% inhibitory concentra tion of 8-15 MM-Further examination of the inhibition by using structural analogues of dequalinium reveals that th...

2006
Shunsuke Hiraguri Tony Godfrey Haruhiko Nakamura Jeremy Graff C'ollin Collins Laleh Shayesteh Norman Doggett Keith Johnson Margaret Wheelock James Herman Stephen Baylin Daniel Pinkel Joe Gray

Loss of E-cadherin (CDH1) function is thought to contribute to pro gression in breast cancer and other solid tumors by increasing prolifera tion, invasion, and/or metastasis. In some cases, the restoration of CDH1 function may be an important therapeutic option. This possibility will depend on the mechanism by which CDH1 is inactivated. Here we present analyses of CDH1 expression, genetic mutat...

2006
David A. Gewirtz Michael S. Orr Frank A. Fornari Joyce K. Randolph Jack C. Yalowich Mary K. Ritke Lawrence F. Povirk Roderick T. Bunch

In the MCF-7 breast iunior cell line, induction of bulk damage to DNA (measured either as total strand breaks or as double-strand breaks I fails to correspond »¡Hi the antiprciliferative activity of the demethylepipodophyllotoxin derivative, VM-26. In contrast, VM-26 produces an early (within 2-3 h) concentration-dependent reduction in e-myc expression (and of UNA synthesis) which parallels i...

2006
Rosalba Torrisi Floriana Pensa Maria Antonietta Orengo Elie Catsafados Paola Ponzani Francesco Boccardo Alberto Costa Andrea Decensi

We studied the effect of fenretinide [/V-(4-hydroxyphenyl)retinamide (4-HPR)], a synthetic analogue of retinoic acid, on plasma insulin-like growth factor I (IGF-I) levels in a consecutive cohort of stage I breast cancer patients belonging to a randomized phase III trial of breast cancer chemoprevention. Thirty-two women receiving 4-HPR 200 mg/daily and 28 untreated controls entered the study. ...

2006
Guofu Fang Brian S. Chang Caryn N. Kim Charles Perkins Craig B. Thompson Kapil N. Bhalla

Taxol, 1-ß-D-arabinofuranosy Icytosine (ara-C), and etoposide induce apoptosis in HL-60 cells that is blocked by overexpression of Bcl-2 or Ikl-\,, A ~60-amino acid "loop"domain of Bcl-2 and Bcl-xLthat contains phosphorylation sites is known to negatively regulate their antiapoptotic function. In the present studies, Taxol-, ara-C-, or etoposide-induced apoptosis was examined in HL-60/Bcl-2A a...

Journal: :Cancer research 1979
J M Quarles M W Sega C K Schenley W Ljinsky

The transplacental host-mediated hamster cell culture assay was used to test a series of solvents, control chemicals, and pesticides and their corresponding /V-nitroso derivatives for transforming activity. In addition to testing for morphological transformation, growth of cells suspended in 0.3% agar and tumorigenicity in nude mice were also determined. No trans forming activity was detected d...

2006
Patricia L. Witt Paul S. Ritch Douglas Reding Timothy L. McAuliffe Linda Westrick Sidney E. Grossberg Ernest C. Borden

Imiquimod [l-(2-methylpropyl)-l//-imidazo[4,5c]quinolin-4-amine] is a compound of low molecular weight that, when administered p.o., induces interferon-a in several animal species and inhibits tumor growth in mice. To determine maximum tolerated dose, toxicity, and biological response in humans, a phase I clinical trial was conducted with 14 eligible cancer patients who received 100-500 mg imiq...

2006
Patricia L. Witt Paul S. Ritch Douglas Reding Timothy L. McAuliffe Linda Westrick Sidney E. Grossberg Ernest C. Borden

Imiquimod [l-(2-methylpropyl)-l//-imidazo[4,5c]quinolin-4-amine] is a compound of low molecular weight that, when administered p.o., induces interferon-a in several animal species and inhibits tumor growth in mice. To determine maximum tolerated dose, toxicity, and biological response in humans, a phase I clinical trial was conducted with 14 eligible cancer patients who received 100-500 mg imiq...

2006
Sylvie Gazzeri Veronique Della Valle Laure Chaussade VéroniqueDella Valle Christian Brambilla Elisabeth Brambilla

n*flfac4ICDIN2nfFSl gene encodes two structurally different pro teins: a cyclin-dcpendent kinase inhibitor called pl6INK4u,which regulates retinohlastoma protein-dependent G, arrest, and a cell cycle inhibitor designated |il')U!l. which arrests cell growth in C,-S and also in G2-M. Whereas inactivation of pI6INK4"has been described as a frequent event in lung cancer, the current function of pl9...

2006
Fu-Shen Wang Carlo Aschele Alberto Sobrero Yu-Ming Chang Joseph R. Bertino

HCT-8 cells become rapidly resistant to either 4-h (HCT-8/4hR) or 7-day (HCT-8/7dR) repeated exposures to fluorouracil (FUra). The HCT8/7dR cells were studied in more detail to determine their mechanism of resistance to FUra. Thymidylate synthase activity, binding of 5-fluorodeoxyuridylate to thymidylate synthase, and incorporation of FUra into RNA were not different between the parental and re...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید